266 related articles for article (PubMed ID: 8306345)
41. Comparative pharmacology of the nonpeptide neuromedin B receptor antagonist PD 168368.
Ryan RR; Katsuno T; Mantey SA; Pradhan TK; Weber HC; Coy DH; Battey JF; Jensen RT
J Pharmacol Exp Ther; 1999 Sep; 290(3):1202-11. PubMed ID: 10454496
[TBL] [Abstract][Full Text] [Related]
42. Stimulation by bombesin and inhibition by bombesin/gastrin-releasing peptide antagonist RC-3095 of growth of human breast cancer cell lines.
Yano T; Pinski J; Groot K; Schally AV
Cancer Res; 1992 Aug; 52(16):4545-7. PubMed ID: 1643647
[TBL] [Abstract][Full Text] [Related]
43. Molecular genetic analysis of two distinct receptors for mammalian bombesin-like peptides.
Battey J; Wada E; Corjay M; Way J; Fathi Z; Shapira H; Harkins R; Wu J; Slattery T; Mann E
J Natl Cancer Inst Monogr; 1992; (13):141-4. PubMed ID: 1327030
[TBL] [Abstract][Full Text] [Related]
44. Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide.
Carney DN; Cuttitta F; Moody TW; Minna JD
Cancer Res; 1987 Feb; 47(3):821-5. PubMed ID: 3026617
[TBL] [Abstract][Full Text] [Related]
45. Effects of intracerebral ventricular administration of gastrin-releasing peptide and its receptor antagonist RC-3095 on learned fear responses in the rat.
Merali Z; Mountney C; Kent P; Anisman H
Behav Brain Res; 2011 Jan; 216(2):519-24. PubMed ID: 20801162
[TBL] [Abstract][Full Text] [Related]
46. 177Lu-AMBA: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer.
Lantry LE; Cappelletti E; Maddalena ME; Fox JS; Feng W; Chen J; Thomas R; Eaton SM; Bogdan NJ; Arunachalam T; Reubi JC; Raju N; Metcalfe EC; Lattuada L; Linder KE; Swenson RE; Tweedle MF; Nunn AD
J Nucl Med; 2006 Jul; 47(7):1144-52. PubMed ID: 16818949
[TBL] [Abstract][Full Text] [Related]
47. Discovery of high affinity bombesin receptor subtype 3 agonists.
Wu JM; Nitecki DE; Biancalana S; Feldman RI
Mol Pharmacol; 1996 Nov; 50(5):1355-63. PubMed ID: 8913368
[TBL] [Abstract][Full Text] [Related]
48. Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.
Breeman WA; de Jong M; Erion JL; Bugaj JE; Srinivasan A; Bernard BF; Kwekkeboom DJ; Visser TJ; Krenning EP
J Nucl Med; 2002 Dec; 43(12):1650-6. PubMed ID: 12468515
[TBL] [Abstract][Full Text] [Related]
49. Bombesin and glucocorticoids stimulate human breast cancer cells to produce endothelin, a paracrine mitogen for breast stromal cells.
Schrey MP; Patel KV; Tezapsidis N
Cancer Res; 1992 Apr; 52(7):1786-90. PubMed ID: 1551109
[TBL] [Abstract][Full Text] [Related]
50. Effects of bombesin family peptides and antagonists on guinea pig nasal mucosal secretion.
Ali M; Gawin AZ; Baraniuk JN
J Pharmacol Exp Ther; 1996 Mar; 276(3):1266-71. PubMed ID: 8786559
[TBL] [Abstract][Full Text] [Related]
51. Characterization, in some human breast cancer cell lines, of gastrin-releasing peptide-like receptors which are absent in normal breast epithelial cells.
Giacchetti S; Gauvillé C; de Crémoux P; Bertin L; Berthon P; Abita JP; Cuttitta F; Calvo F
Int J Cancer; 1990 Aug; 46(2):293-8. PubMed ID: 2166713
[TBL] [Abstract][Full Text] [Related]
52. Gastrin-releasing peptide receptor in rat brain membranes: specific binding and stimulation of phosphoinositide breakdown.
Hollingsworth EB
Mol Pharmacol; 1989 May; 35(5):689-94. PubMed ID: 2542758
[TBL] [Abstract][Full Text] [Related]
53. Bombesin, neuromedin B and neuromedin C interact with a common rat pancreatic phosphoinositide-coupled receptor, but are differentially regulated by guanine nucleotides.
Sekar MC; Uemura N; Coy DH; Hirschowitz BI; Dickinson KE
Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):163-9. PubMed ID: 1720612
[TBL] [Abstract][Full Text] [Related]
54. Systematic development of bombesin/gastrin-releasing peptide antagonists.
Coy DH; Jensen RT; Jiang NY; Lin JT; Bogden AE; Moreau JP
J Natl Cancer Inst Monogr; 1992; (13):133-9. PubMed ID: 1389686
[TBL] [Abstract][Full Text] [Related]
55. Effects of bombesin on human small cell lung cancer cells: evidence for a subset of bombesin non-responsive cell lines.
Kado-Fong H; Malfroy B
J Cell Biochem; 1989 Aug; 40(4):431-7. PubMed ID: 2550492
[TBL] [Abstract][Full Text] [Related]
56. Bombesin/GRP-preferring and neuromedin B-preferring receptors in the rat urogenital system.
Kilgore WR; Mantyh PW; Mantyh CR; McVey DC; Vigna SR
Neuropeptides; 1993 Jan; 24(1):43-52. PubMed ID: 8381528
[TBL] [Abstract][Full Text] [Related]
57. [Leu13-psi(CH2NH)Leu14]bombesin is a specific bombesin receptor antagonist in Swiss 3T3 cells.
Woll PJ; Coy DH; Rozengurt E
Biochem Biophys Res Commun; 1988 Aug; 155(1):359-65. PubMed ID: 2843183
[TBL] [Abstract][Full Text] [Related]
58. Characterization of bombesin/gastrin-releasing peptide receptors in membranes of MKN45 human gastric cancer.
Halmos G; Pinski J; Szoke B; Schally AV
Cancer Lett; 1994 Sep; 85(1):111-8. PubMed ID: 7923093
[TBL] [Abstract][Full Text] [Related]
59. Adenoviral-mediated delivery of gastrin-releasing peptide receptor results in specific tumor localization of a bombesin analogue in vivo.
Rosenfeld ME; Rogers BE; Khazaeli MB; Mikheeva G; Raben D; Mayo MS; Curiel DT; Buchsbaum DJ
Clin Cancer Res; 1997 Jul; 3(7):1187-94. PubMed ID: 9815798
[TBL] [Abstract][Full Text] [Related]
60. Non-peptide bombesin receptor antagonists, kuwanon G and H, isolated from mulberry.
Mihara S; Hara M; Nakamura M; Sakurawi K; Tokura K; Fujimoto M; Fukai T; Nomura T
Biochem Biophys Res Commun; 1995 Aug; 213(2):594-9. PubMed ID: 7646517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
